Literature DB >> 28157516

PNPLA3, TM6SF2, and MBOAT7 Genotypes and Coronary Artery Disease.

Nynke Simons1, Aaron Isaacs2, Ger H Koek3, Sanela Kuč4, Nicolaas C Schaper4, Martijn C G J Brouwers5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28157516     DOI： 10.1053/j.gastro.2016.12.020

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  27 in total

1.  17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease.

Authors:  Yanling Ma; Olga V Belyaeva; Philip M Brown; Koji Fujita; Katherine Valles; Suman Karki; Ynto S de Boer; Christopher Koh; Yanhua Chen; Xiaomeng Du; Samuel K Handelman; Vincent Chen; Elizabeth K Speliotes; Cara Nestlerode; Emmanuel Thomas; David E Kleiner; Joseph M Zmuda; Arun J Sanyal; Natalia Y Kedishvili; T Jake Liang; Yaron Rotman
Journal:  Hepatology       Date:  2019-03-05       Impact factor: 17.425

2.  Human PNPLA3-I148M variant increases hepatic retention of polyunsaturated fatty acids.

Authors:  Panu K Luukkonen; Auli Nick; Maarit Hölttä-Vuori; Christoph Thiele; Elina Isokuortti; Susanna Lallukka-Brück; You Zhou; Antti Hakkarainen; Nina Lundbom; Markku Peltonen; Marju Orho-Melander; Matej Orešič; Tuulia Hyötyläinen; Leanne Hodson; Elina Ikonen; Hannele Yki-Järvinen
Journal:  JCI Insight       Date:  2019-08-22

Review 3.  Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology.

Authors:  Mohammed Eslam; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-10-22       Impact factor: 46.802

4.  Association between PNPLA3 rs738409 G variant and MRI cerebrovascular disease biomarkers.

Authors:  Neal S Parikh; Nicole Dueker; Dalila Varela; Victor J Del Brutto; Tatjana Rundek; Clinton B Wright; Ralph L Sacco; Mitchell S V Elkind; Jose Gutierrez
Journal:  J Neurol Sci       Date:  2020-06-20       Impact factor: 3.181

5.  Cardiovascular Disease in Nonalcoholic Steatohepatitis: Screening and Management.

Authors:  Hersh Shroff; Lisa B VanWagner
Journal:  Curr Hepatol Rep       Date:  2020-06-29

6.  Patatin-like phospholipase domain containing 3 variants differentially impact metabolic traits in individuals at high risk for cardiovascular events.

Authors:  Sabrina Rüschenbaum; Katharina Schwarzkopf; Mireen Friedrich-Rust; Florian Seeger; Fabian Schoelzel; Yolanda Martinez; Stefan Zeuzem; Jörg Bojunga; Christian M Lange
Journal:  Hepatol Commun       Date:  2018-06-06

Review 7.  MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD.

Authors:  Marica Meroni; Miriam Longo; Anna L Fracanzani; Paola Dongiovanni
Journal:  EBioMedicine       Date:  2020-07-03       Impact factor: 8.143

8.  Relationship between AGT rs2493132 polymorphism and the risk of coronary artery disease in patients with NAFLD in the Chinese Han population.

Authors:  Mengzhen Dong; Shousheng Liu; Mengke Wang; Yifen Wang; Yongning Xin; Shiying Xuan
Journal:  J Int Med Res       Date:  2021-07       Impact factor: 1.671

9.  NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects.

Authors:  Eeva Sliz; Sylvain Sebert; Peter Würtz; Antti J Kangas; Pasi Soininen; Terho Lehtimäki; Mika Kähönen; Jorma Viikari; Minna Männikkö; Mika Ala-Korpela; Olli T Raitakari; Johannes Kettunen
Journal:  Hum Mol Genet       Date:  2018-06-15       Impact factor: 6.150

10.  Predictors of Liver Fat and Stiffness in Non-Alcoholic Fatty Liver Disease (NAFLD) - an 11-Year Prospective Study.

Authors:  Susanna Lallukka; Sanja Sädevirta; Markus T Kallio; Panu K Luukkonen; You Zhou; Antti Hakkarainen; Nina Lundbom; Marju Orho-Melander; Hannele Yki-Järvinen
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.